| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 05/24/2006 | EP1603405A4 Methods for treating cancer using perna canaliculus component(s) and extracts of perna canaliculus |
| 05/24/2006 | EP1506185B1 Compounds and their use as inhibitors of 5-ht |
| 05/24/2006 | CN1777673A Treatment of IgA1 deposition diseases |
| 05/24/2006 | CN1777612A New piperidinylamino-thieno[2,3-d] pyrimidine compounds |
| 05/24/2006 | CN1777576A Compounds for the treatment of metabolic disorders |
| 05/24/2006 | CN1777448A Vaccine accelerator factor (VAF) for improvement of vaccinations in poultry |
| 05/24/2006 | CN1777440A Method for preparation of site-specific protein conjugates |
| 05/24/2006 | CN1777439A Somatostatin vectors |
| 05/24/2006 | CN1777436A Anti-angiogenic and anti-tumoral properties of beta and gamma secretase inhibitors |
| 05/24/2006 | CN1257160C Aimoquinoline and aminopyridine derivatives and their use as adenosine A3 ligands |
| 05/23/2006 | USRE39104 Dissolving a mixture of progesterone and estradiol, hydrophilic polymer carrier in a volatile organic solvent, evaporting to desolventize, precipitating to form powders; mouth administering, fast and great resorption; hormone replacement therapy, hormonal insufficiency |
| 05/23/2006 | US7049479 Ultra thin film transdermal/dermal or transmucosal/mucosal delivery system |
| 05/23/2006 | US7049444 3-azabicyclo[3.1.0]hexane derivatives useful in therapy |
| 05/23/2006 | US7049438 Quinazoline derivatives for treatment of tumours |
| 05/23/2006 | US7049314 Cyclopentyl indole derivatives |
| 05/23/2006 | US7048947 Sustained-release preparation |
| 05/23/2006 | CA2411766C Non-nucleoside reverse transcriptase inhibitors |
| 05/23/2006 | CA2173747C Calcium receptor-active arylalkyl amines |
| 05/18/2006 | WO2005117577A3 Model for neurodegenerative disorders |
| 05/18/2006 | WO2005051306A3 Apparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease |
| 05/18/2006 | WO2005051301A3 Heterocyclic inhibitors of mek and methods of use thereof |
| 05/18/2006 | WO2005041902A3 Anion-binding polymers and uses thereof |
| 05/18/2006 | WO2005041866A3 Pharmaceutical formulations, methods and dosing regimens for the treatment and prevention of acute coronary syndromes |
| 05/18/2006 | WO2005041864A3 Combination of cyclooxygenase-2 inhibitor and phosphodiesterase 4 inhibitor and method |
| 05/18/2006 | WO2005041852A3 Keratin gel and the types 2, 4 and 6 of collagens of frog protein |
| 05/18/2006 | WO2005032484A9 Alkoxy substituted imidazoquinolines |
| 05/18/2006 | WO2005027842A8 Combinations of drugs for the treatment of neoplasms |
| 05/18/2006 | WO2005013919A3 Treatment using dantrolene |
| 05/18/2006 | WO2005009339A3 Inflammatory bowel diseases |
| 05/18/2006 | WO2004110355A3 Compositions and methods including a recombinant human mab that promotes cns remyelination |
| 05/18/2006 | WO2004091533A3 Delivery systems of homogeneous, thermoreversible gel film containing kappa-2 carrageenan |
| 05/18/2006 | WO2004091532A3 Homogeneous, thermoreversible gel containing reduced viscosity carrageenan and products made therefrom |
| 05/18/2006 | WO2004014306A3 Compositions and methods for the treatment of diseases exhibiting protein misassembly and aggregation |
| 05/18/2006 | US20060106077 Pin1-Modulating compounds and methods of use thereof |
| 05/18/2006 | US20060106058 Chemical compounds |
| 05/18/2006 | US20060105977 Desmoglein 4 is a novel gene involved in hair growth |
| 05/18/2006 | US20060105371 Using surface-mediated protein transfected cell microarrays to screen polypeptide and enzyme activities; high throughput assay; drug screening |
| 05/18/2006 | US20060105344 Modulation of deubiquitinase family members |
| 05/18/2006 | US20060104988 Vaccines against hiv-1 tat protein to generate neutralizing antibodies |
| 05/18/2006 | US20060104986 Induce immunology response; administering yeast vehicle and antigen |
| 05/18/2006 | US20060104971 Multivalent lymphotoxin beta receptor agonists and therapeutic uses thereof |
| 05/18/2006 | US20060104961 Mechanisms of myoblast transfer in treating heart failure |
| 05/18/2006 | US20060104946 Method for treating inflammatory bowel disease |
| 05/18/2006 | US20060104909 Abuse-resistant pharmaceutical compositions |
| 05/17/2006 | EP1657255A1 Novel protein and method for producing the protein |
| 05/17/2006 | EP1656389A1 A method for cleaving proteins |
| 05/17/2006 | EP1656359A2 Macrocyclic beta-secretase inhibitors for the treatment of alzheimer's disease |
| 05/17/2006 | EP1656183A1 Treatment of male sexual dysfunction |
| 05/17/2006 | EP1656153A2 Appetite control compositions and methods of use |
| 05/17/2006 | EP1656146A2 Mitotic kinesin inhibitors |
| 05/17/2006 | EP1656142A2 6-cycloamino-2-quinolinone derivatives as androgen receptor modulator compounds |
| 05/17/2006 | EP1656129A2 Blockade of mtor to prevent a hormonal adaptive response |
| 05/17/2006 | EP1656116A2 Polymeric systems for controlled drug therapy |
| 05/17/2006 | EP1656115A2 Controlled release compositions |
| 05/17/2006 | EP1656102A2 Compositions for delivering 5-ht agonists across the oral mucosa and methods of use thereof |
| 05/17/2006 | EP1656096A2 Methods of reducing risk of infection from pathogens |
| 05/17/2006 | EP1656095A2 N,n-dihalogenated amino acids and derivatives |
| 05/17/2006 | EP1656094A2 Methods of improving the safety of zonisamide therapy |
| 05/17/2006 | EP1656088A2 Methods of reducing risk of infection from pathogens |
| 05/17/2006 | EP1345929B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1345927B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1345926B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1345925B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1330293B1 Controlled release composition comprising lactic acid polymer, and method of producing the same |
| 05/17/2006 | EP1115387B1 Anti-microbial-adhesion fraction derived from vaccinium |
| 05/17/2006 | EP1109787B1 Arylpiperazines and their use as metalloproteinase inhibiting agents (mmp) |
| 05/17/2006 | EP1007101B1 Improvements in or relating to diagnostic/therapeutic agents |
| 05/17/2006 | EP0975668B1 MODIFIED TNFalpha MOLECULES, DNA ENCODING SUCH MODIFIED TNFalpha MOLECULES AND VACCINES COMPRISING SUCH MODIFIED TNFalpha MOLECULES AND DNA |
| 05/17/2006 | CN1774261A Methods and compositions for the treatment of diseases of the eye |
| 05/17/2006 | CN1774259A Parenteral formulations of peptides for the treatment of systemic lupus erythematosus |
| 05/17/2006 | CN1774246A Substituted isochroman compounds for the treatment of metabolic disorders, cancer and other diseases |
| 05/17/2006 | CN1774244A Compounds for the treatment of metabolic disorders |
| 05/17/2006 | CN1774242A Methods for preparation and use of 1alpha,24(s)-dihydroxyvitamin d2 |
| 05/17/2006 | CN1772733A Cyanopyrrolidine derivatives |
| 05/17/2006 | CN1256085C Sertraline salts and substained-release dosage forms of sertraline |
| 05/16/2006 | US7045159 Antiviral substances from plant cuticular and epiciticular material |
| 05/16/2006 | CA2273509C Aerosol device with base of fixing material alcoholic compositions containing anionic grafted siliconized polymers |
| 05/11/2006 | WO2006048862A2 The use of a protease or a protease inhibitor for the manufacture of medicaments |
| 05/11/2006 | WO2006048671A1 Polyamine compositions |
| 05/11/2006 | WO2006048501A1 A transmucosal veterinary composition comprising detomidine |
| 05/11/2006 | WO2005051317A3 Substituted imidazo ring systems and methods |
| 05/11/2006 | WO2005051287A3 Method and device for umbilicus protection during abdominal surgery |
| 05/11/2006 | WO2005048951A3 A novel human g-protein coupled receptor, hgprbmy8, expressed highly in brain |
| 05/11/2006 | WO2005018551A3 Oxime substituted imidazo-containing compounds |
| 05/11/2006 | WO2005016250A3 Cell therapy for neurometabolic disorders |
| 05/11/2006 | WO2004110381A3 Pharmaceutical compositions comprising active vitamin d compounds |
| 05/11/2006 | WO2004110363A3 Method of inhibiting tumor growth with anti-tissue factor antibodies |
| 05/11/2006 | WO2004096151A3 Methods and devices for the sustained release of multiple drugs |
| 05/11/2006 | WO2004066955A3 Slowly digestible starch |
| 05/11/2006 | WO2004041204A3 Methods and compositions for treating neurodegenerative diseases |
| 05/11/2006 | US20060100370 Random and non-random alkylene oxide polymer alloy compositions |
| 05/11/2006 | US20060100290 Treatment of allergic rhinitis and asthma |
| 05/11/2006 | US20060100289 Nitrone compounds, pharmaceutical compositions containing the same and methods for treating inflammation and neuropathic pain |
| 05/11/2006 | US20060100286 Treatment of canine hemangiosarcoma with a histone deacetylase inhibitor |
| 05/11/2006 | US20060100273 Anhydrous silver dihydrogen citrate compositions |
| 05/11/2006 | US20060100164 11-N-[4-(4-Pyridin-3-yl-imidazol-1-yl)-butyl]-6-O-methyl-5-O-(3-dimethylamino-2-hydroxy-propoxy)-3-oxo-erythronolide A, 11,12-carbamate; functionalized macrolides; antiviral, antiprotozoal, anticancer and antigastrointestinal |
| 05/11/2006 | US20060100159 Preventing desensitization of receptors |
| 05/11/2006 | US20060099255 solid dosage forms for oral administration, reducing the range in daily dosages required to control pain in human patients |
| 05/11/2006 | US20060099224 Methods and compositions concerning poxviruses and cancer |
| 05/11/2006 | US20060099200 Pretreatment or post exposure treatment for exposure to a toxic substance by pulmonary delivery (inhaler) of a bioscavenger |